Analysts expect over 2020 decreasing revenue Pfizer, relatively high dividend

Tomorrow the American Pfizer will publish its past quarters figures. Over the current book year the company from New York City's total revenue could be around 48.08 billion USD (consensus estimates). This is slightly lower than 2019's revenue of 51.75 billion USD.

Historical revenues and results Pfizer plus estimates 2020

Pfizer

The analysts expect for 2020 a net profit of 15.43 billion USD. The majority of the analysts expects for this year a profit per share of 2.81 USD. Based on this the price/earnings-ratio is 12.78.

Huge dividend Pfizer

Analysts expect a dividend of 1.45 USD per share. Thus the dividend yield equals 4.04 percent. The average dividend yield of the pharmaceutical companies is a limited 0.16 percent.

Latest estimates around 39 USD

The latest 3 recommendations for the pharmaceutical company were provided by RBC Capital Markets, Goldman Sachs and Barclays .

Pfizer 's market capitalization is based on the number of outstanding shares around 205.24 billion USD. The Pfizer stock was the past 12 months quite unstable. Since last February the stock is 6 percent higher. This year the stock price moved between 26 and 43 dollar.

Historical stock prices Pfizer from 2007 till 2020

Click here for dividend Pfizer. On Friday the stock closed at 35.9 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.